Zobrazeno 1 - 10
of 20
pro vyhledávání: '"C. M. Zwaan"'
Autor:
A. Vora, T. Bhatla, D. Teachey, F. Bautista, J. Moppett, P. Velasco Puyó, C. Micalizzi, C. Rossig, N. Shukla, G. Gilad, F. Locatelli, A. Baruchel, C. M. Zwaan, E. A. Raetz, N. Bandyopadhyay, L. Lopez Solano, R. M. Dennis, R. Carson, L. E. Hogan
Publikováno v:
HemaSphere, Vol 6, Pp 260-261 (2022)
Externí odkaz:
https://doaj.org/article/199bcd5e5a07454880929b653eac0420
Autor:
C. J. Hess, N. Ameziane, G. J. Schuurhuis, A. Errami, F. Denkers, G. J. L. Kaspers, J. Cloos, H. Joenje, D. Reinhardt, G. J. Ossenkoppele, C. M. Zwaan, Q. Waisfisz
Publikováno v:
Cellular Oncology, Vol 30, Iss 4, Pp 299-306 (2008)
Objective: Inactivation of the FA-BRCA pathway results in chromosomal instability. Fanconi anaemia (FA) patients have an inherited defect in this pathway and are strongly predisposed to the development of acute myeloid leukaemia (AML). Studies in spo
Externí odkaz:
https://doaj.org/article/93ab040d3a0646af9e9ac38a739bc342
PurposeLimited sampling strategies (LSS) lower the burden of PK-guided dosing, but an extensive evaluation of LSS for BAX 855 (Adynovi®) is currently lacking. This study aimed to develop a LSS for BAX 855 and combine this with a LSS of a standard ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92143af9f4ade4fd65cedd92e0bcb49e
https://doi.org/10.21203/rs.3.rs-1986570/v1
https://doi.org/10.21203/rs.3.rs-1986570/v1
Autor:
Roger J. M. Brüggemann, M.T. van der Beek, Alexander Schauwvlieghe, R. M. Verdijk, Robbert G. M. Bredius, Bart J. A. Rijnders, B. F. Goemans, C. M. Zwaan, Frans J. Smiers
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 22, Iss, Pp 354-357 (2020)
Journal of Global Antimicrobial Resistance, 22, 354-357. Elsevier
Journal of Global Antimicrobial Resistance, 22, pp. 354-357
Journal of Global Antimicrobial Resistance, 22, 354-357. ELSEVIER SCI LTD
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
Journal of Global Antimicrobial Resistance, 22, 354-357
Journal of Global Antimicrobial Resistance, 22, 354-357. Elsevier
Journal of Global Antimicrobial Resistance, 22, pp. 354-357
Journal of Global Antimicrobial Resistance, 22, 354-357. ELSEVIER SCI LTD
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
Journal of Global Antimicrobial Resistance, 22, 354-357
Objectives: In the pre-azole era, central nervous system (CNS) infections with Aspergillus had a dismal outcome. Survival improved with voriconazole but CNS infections caused by azole-resistant Aspergillus fumigatus preclude its use. Intravenous lipo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5506916ef68a6837ca385db5476501ef
https://doi.org/10.1016/j.jgar.2020.03.016
https://doi.org/10.1016/j.jgar.2020.03.016
Autor:
C. M. Zwaan, M. A. Benninga, Irma M. Hein, Robert Lindeboom, R. J. L. Lindauer, J. B. van Goudoever, Pieter W. Troost
Publikováno v:
Kind en Adolescent, 37(3), 174-184. Bohn Stafleu van Loghum
Inleiding Om inhoud te geven aan het autonomiebeginsel bij kinderen bij het nemen van medische beslissingen over de eigen behandeling is het essentieel te weten in hoeverre zij hiertoe wilsbekwaam zijn. In Nederland wordt uitgegaan van een wettelijk
Publikováno v:
The Netherlands journal of medicine. 75(10)
The protein kinase inhibitor dasatinib, targeting BCR-ABL and Src family kinases, is used in chronic myeloid leukaemia and Philadelphia-chromosome positive acute lymphoblastic leukaemia. The Netherlands Pharmacovigilance Centre Lareb has received one
Autor:
N. K. van Eijkelenburg, M. M. van den Heuvel-Eibrink, H. Hasle, C. M. Niemeyer, M. N. Dworzak, M. Zecca, M. I. Lopez, R. Hoogendijk, J. Janssen, A. Huitema, C. M. Zwaan
Publikováno v:
HemaSphere. 3:227
Autor:
Eline J M, Bertrums, Arjan, Buijs, Martine, van Grotel, Natasja, Dors, Jasmijn D E, de Rooij, Valerie, de Haas, Sanne, Hopman, Marjolijn C J, Jongmans, C M, Zwaan, Marry M, van den Heuvel-Eibrink
Publikováno v:
Pediatric bloodcancer. 64(3)
Transient myeloproliferative disorder (TMD) is a leukemia type that occurs typically in newborns. In Down syndrome, TMD is referred to as transient abnormal myelopoiesis (TAM).
Autor:
H, Segers, J C, van der Heyden, E L T, van den Akker, R R, de Krijger, C M, Zwaan, M M, van den Heuvel-Eibrink
Publikováno v:
Pediatric bloodcancer. 53(2)
Cushing syndrome as the presenting symptom of a malignant renal tumor in children is rare. We report the first case of paraneoplastic Cushing syndrome due to a Wilms tumor, in which clinical and biological signs of hypercortisolism regressed during p
Autor:
D, Reinhardt, S, Diekamp, G, Fleischhack, C, Corbacioglu, H, Jürgens, M, Dworzak, G, Kaspers, U, Creutzig, C M, Zwaan
Publikováno v:
Onkologie. 27(3)
Gemtuzumab ozogamicin (GO) is an immunoconjugate consisting of the CD33 antibody and calicheamicin, a potent cytotoxic agent. Developed for targeted treatment of CD33-positive AML, studies in adults showed its efficacy in relapsed and refractory AML.